Robaxin description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Home SubjectClassCompaniesIngredientsNames A-Z
Search
Home – Robaxin

Robaxin

REMEDYREPACK INC.


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

ROBAXIN DESCRIPTION



Robaxin




CLINICAL PHARMACOLOGY



Pharmacokinetics



Special populations




Renally impaired


Hepatically impaired

INDICATIONS & USAGE


ROBAXIN CONTRAINDICATIONS


WARNINGS


PRECAUTIONS,Pregnancy).
 Use In Activities Requiring Mental Alertness

PRECAUTIONS

Information for Patients


DRUG INTERACTIONS

WARNINGSandPRECAUTIONSfor interaction with CNS drugs and alcohol.

DRUG & OR LABORATORY TEST INTERACTIONS


CARCINOGENESIS & MUTAGENESIS & IMPAIRMENT OF FERTILITY


PREGNANCY





WARNINGS).

NURSING MOTHERS


PEDIATRIC USE


ROBAXIN ADVERSE REACTIONS









OVERDOSAGE


DOSAGE & ADMINISTRATION








HOW SUPPLIED








STORAGE AND HANDLING

Store at controlled room temperature, between 20and 25(68and 77
Dispense in tight container.

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL SECTION














Robaxin






Robaxin

Robaxin

Methocarbamol TABLET

Product Information

Product Type Human prescription drug label Item Code (Source) NDC:52125-024(NDC:52244-429)
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
METHOCARBAMOL METHOCARBAMOL 500 mg

Inactive Ingredients

Ingredient Name Strength
titanium dioxide
FD&C YELLOW NO. 6
hydroxypropyl cellulose
HYPROMELLOSES
MAGNESIUM STEARATE
D&C YELLOW NO. 10
POLYSORBATE 20
povidone
saccharin sodium
SODIUM LAURYL SULFATE
SODIUM STARCH GLYCOLATE TYPE A POTATO
STARCH, CORN
STEARIC ACID
propylene glycol

Product Characteristics

Color Size Imprint Code Shape
orange 13 mm Robaxin;500;SP ROUND

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:52125-024-02 30 in 1 BLISTER PACK

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA011011 2012-08-16


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.
Designed by Tank
Developed by KB.MD